Last edition
News about
Analog Devices Receives FDA Clearance and Launches Sensinel Cardiopulmonary Management System
This compact wearable device represents a breakthrough in chronic disease management, particularly for conditions like heart failure, and marks the company's first FDA clearance in its 59-year history.
Cytovale Appoints Christopher Slachta as Chief Operating Officer
With more than 20 years of experience in the medical device and diagnostic industry, Slachta will lead operations as Cytovale ramps up production of its FDA-cleared rapid sepsis diagnosis test — IntelliSep®.
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
The acquisition is subject to customary closing conditions and is expected to be completed in the first quarter of Haemonetics' fiscal year 2025.
Ariceum Therapeutics Launches Cutting-Edge Laboratory Facility in Berlin Headquarters
These cutting-edge facilities are dedicated to advancing the company's next-generation radiopharmaceutical pipeline candidates and facilitating the transition of emerging products into clinical trials.
BridgeBio Pharma and Bayer Partner to Bring Acoramidis to European Market
Under this agreement, BridgeBio is set to receive up to USD 310 million USD, including upfront and near-term milestone payments, along with additional undisclosed sales milestones.
Cardiotrack Secures USD 2 Million in Pre-Series A Funding
The pre-series A funding is led by Girish Narasimhan, Managing Director & Principal, Corporate Finance Associates Worldwide Inc. along with seasoned professional and co-investor Y S Shashidhar, Advisor, Dubai Holdings LLC.
Affidea Group Enters into Binding Agreement to Acquire MedEuropa Romania
Affidea Group, Europe's largest provider of advanced diagnostics, multi-speciality polyclinics and Centres of Excellence, announced that it has entered into a binding agreement to acquire MedEuropa Romania, a renowned cancer care provider.
Hugel Receives US FDA Approval for Its Botulinum Toxin Letybo
Hugel announced that the company has received marketing approval from the U.S. Food and Drug Administration (FDA) on the 29th (local time) for 50 units and 100 units of its botulinum toxin Letybo.
In his address, Dr. Mandaviya emphasised the importance of the domestic production of medicines and medical devices.
Walden Group Makes Strategic Entry into Italian Healthcare Logistics Market
Italy, with its 2.4 percent share of the global drug consumption market, has long been a target for Walden Group.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy